247 related articles for article (PubMed ID: 26944365)
1. A study of margin width and local recurrence in breast conserving therapy for invasive breast cancer.
Dixon JM; Thomas J; Kerr GR; Williams LJ; Dodds C; Kunkler IH; Macaskill EJ
Eur J Surg Oncol; 2016 May; 42(5):657-64. PubMed ID: 26944365
[TBL] [Abstract][Full Text] [Related]
2. Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.
Ekatah GE; Turnbull AK; Arthur LM; Thomas J; Dodds C; Dixon JM
Eur J Surg Oncol; 2017 Nov; 43(11):2029-2035. PubMed ID: 28917445
[TBL] [Abstract][Full Text] [Related]
3. Importance of margin width in breast-conserving treatment of early breast cancer.
Bodilsen A; Bjerre K; Offersen BV; Vahl P; Amby N; Dixon JM; Ejlertsen B; Overgaard J; Christiansen P
J Surg Oncol; 2016 May; 113(6):609-15. PubMed ID: 26991020
[TBL] [Abstract][Full Text] [Related]
4. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
5. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
6. Close/positive margins after breast-conserving therapy: additional resection or no resection?
Wood WC
Breast; 2013 Aug; 22 Suppl 2():S115-7. PubMed ID: 24074771
[TBL] [Abstract][Full Text] [Related]
7. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.
Bosma SC; van der Leij F; van Werkhoven E; Bartelink H; Wesseling J; Linn S; Rutgers EJ; van de Vijver MJ; Elkhuizen PH
Breast Cancer Res Treat; 2016 Apr; 156(2):391-400. PubMed ID: 27008183
[TBL] [Abstract][Full Text] [Related]
8. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.
Moran MS; Schnitt SJ; Giuliano AE; Harris JR; Khan SA; Horton J; Klimberg S; Chavez-MacGregor M; Freedman G; Houssami N; Johnson PL; Morrow M
Ann Surg Oncol; 2014 Mar; 21(3):704-16. PubMed ID: 24515565
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
[TBL] [Abstract][Full Text] [Related]
10. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy.
Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069
[TBL] [Abstract][Full Text] [Related]
11. Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.
Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Inoue K; Tabei T
Breast; 2009 Aug; 18(4):238-43. PubMed ID: 19625190
[TBL] [Abstract][Full Text] [Related]
12. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer.
McIntosh A; Freedman G; Eisenberg D; Anderson P
Am J Clin Oncol; 2007 Apr; 30(2):146-51. PubMed ID: 17414463
[TBL] [Abstract][Full Text] [Related]
13. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
[TBL] [Abstract][Full Text] [Related]
14. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
15. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
16. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
18. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
[TBL] [Abstract][Full Text] [Related]
19. Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.
Kauer-Dorner D; Pötter R; Resch A; Handl-Zeller L; Kirchheiner K; Meyer-Schell K; Dörr W
Radiother Oncol; 2012 Jan; 102(1):96-101. PubMed ID: 21907439
[TBL] [Abstract][Full Text] [Related]
20. Surgical margin and breast recurrence after breast-conserving therapy.
Horiguchi J; Iino Y; Takei H; Maemura M; Yokoe T; Niibe H; Yamakawa M; Nakajima T; Oyama T; Morishita Y
Oncol Rep; 1999; 6(1):135-8. PubMed ID: 9864416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
